AME Clinical Trials Review

Aims and Scope

AME Clinical Trials Review (ISSN 3005-6152; AME Clin Trials Rev; ACTR) is an international, open-access, peer-reviewed online journal, publishing reviews and commentaries on clinical trials in all phases.

ACTR is dedicated to sharing insights of the key opinion leaders to stimulate thought and discussion on all aspects of clinical trials, including but not limited to the design, conduct, analysis, regulation and ethics. It is the ultimate goal of the journal that the stimulated discussion will facilitate the translation of the findings of clinical trials from bench to bedside, and to clinical practice.

ACTR upholds a rigorous peer review process and high-quality publication standards. ACTR only publishes reviews, commentaries or letters on all phases of clinical trials and does not accept other types of manuscripts (e.g., original articles, etc.). ACTR welcomes unsolicited submissions and also proactively invites specialists to comment on valuable clinical trials.

The entire submission and peer review process are managed through OJS system, an electronic system, which provides an efficient way and ensure a rapid turnaround of papers submission, review and publication.

Publication Schedule

ACTR follows a bimonthly publication model (February, April, June, August, October, December).

Information for Authors

ACTR follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal. Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.

Submission Turnaround Time

• In-house review: 1 week
• External peer review: 1-3 months
• Publication Ahead of Print: within 1 month after being accepted
• Formal publication: within 1-3 months after being accepted.

Open Access Statement

This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.

Free access and usage

Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:

• this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
• the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
• no derivatives including remix, transform, or build upon the material was allowed for distribution.

The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright

For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to ACTR, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.

For any inquiry/special circumstance on the copyright, commercial usage or adaptation of ACTR articles, please contact: permissions@amegroups.com

For reprint order, please contact: sales@amegroups.com

Support for Authors to Comply with Funding Body Mandates

We work with authors of research articles supported by funding bodies with open access mandates to ensure that authors can meet their funders’ requirements for public access to research results.

In addition, we offer further support for authors who are required to comply with funding body mandates, including but not limited to:

• All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. If a specific open access license is needed, please contact the editorial office for confirmation before submission. Example of statements in a published article: https://jgo.amegroups.org/article/view/76355/html.
• No copyright is claimed for any work of the U.S. government. Example of statements in published articles: https://actr.amegroups.org/article/view/8875; https://med.amegroups.org/article/view/8358/html.

Editorial Office

Email: actr@amegroups.com

Publisher Information

ACTR is published by AME Publishing Company.

Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.

Updated on March 27, 2024